Comment on "Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition"
- PMID: 22879486
- DOI: 10.1126/science.1222519
Comment on "Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition"
Abstract
Ray et al. (Reports, 29 July 2011, p. 637) assume that clozapine-N4-oxide (CNO) represents a "biologically inert synthetic ligand" that selectively activates the M4 muscarinic receptor-based DREADD (designer receptor exclusively activated by a designer drug). In contrast, due to the redox cycling of CNO with clozapine and to their cell membrane permeability, CNO is biologically active and its conversion products are capable of undermining DREADD effects.
Comment on
-
Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition.Science. 2011 Jul 29;333(6042):637-42. doi: 10.1126/science.1205295. Science. 2011. PMID: 21798952 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
